These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32016716)

  • 1. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
    Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
    J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma.
    Tinkle CL; Simone B; Chiang J; Li X; Campbell K; Han Y; Li Y; Hover LD; Molitoris JK; Becksfort J; Lucas JT; Patay Z; Baker SJ; Broniscer A; Merchant TE
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):838-847. PubMed ID: 31785339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma.
    Hayashi A; Ito E; Omura M; Aida N; Tanaka M; Tanaka Y; Sato H; Miyagawa N; Yokosuka T; Iwasaki F; Hamanoue S; Goto H
    Pediatr Int; 2020 Jan; 62(1):47-51. PubMed ID: 31785177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
    Mankuzhy NP; Tringale KR; Dunkel IJ; Farouk Sait S; Souweidane MM; Khakoo Y; Karajannis MA; Wolden S
    Pediatr Blood Cancer; 2024 May; 71(5):e30929. PubMed ID: 38430472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis.
    Janssens GO; Jansen MH; Lauwers SJ; Nowak PJ; Oldenburger FR; Bouffet E; Saran F; Kamphuis-van Ulzen K; van Lindert EJ; Schieving JH; Boterberg T; Kaspers GJ; Span PN; Kaanders JH; Gidding CE; Hargrave D
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):315-20. PubMed ID: 22682807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reirradiation for diffuse intrinsic pontine glioma: prognostic radiomic factors at progression.
    Wawrzuta D; Chojnacka M; Drogosiewicz M; Pędziwiatr K; Dembowska-Bagińska B
    Strahlenther Onkol; 2024 Sep; 200(9):797-804. PubMed ID: 38748214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma.
    Muroi A; Mizumoto M; Ishikawa E; Ihara S; Fukushima H; Tsurubuchi T; Sakurai H; Matsumura A
    Childs Nerv Syst; 2020 Mar; 36(3):507-512. PubMed ID: 31728705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
    DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
    J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of socioeconomic status on clinical outcomes of diffuse midline glioma and diffuse intrinsic pontine glioma.
    Lee JH; Holste KG; Bah MG; Franson AT; Garton HJL; Maher CO; Muraszko KM
    J Neurosurg Pediatr; 2024 Jun; 33(6):507-515. PubMed ID: 38489807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
    Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
    Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Impact of Radiotherapy in Conjunction with Temozolomide in Diffuse Intrinsic Pontine Glioma: A Systematic Review and Meta-Analysis.
    Shi S; Lu S; Jing X; Liao J; Li Q
    World Neurosurg; 2021 Apr; 148():e565-e571. PubMed ID: 33476781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated Radiation Therapy For Diffuse Intrinsic Pontine Glioma: A Noninferiority Randomized Study Including 253 Children.
    Zaghloul MS; Nasr A; Tolba M; Refaat A; Youssef A; Mosaab A; Enayet A; Arafa O; Maher E; Eldebawy E
    Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):360-368. PubMed ID: 35150788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis.
    Lu VM; Welby JP; Mahajan A; Laack NN; Daniels DJ
    Childs Nerv Syst; 2019 May; 35(5):739-746. PubMed ID: 30879125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial.
    Zaghloul MS; Eldebawy E; Ahmed S; Mousa AG; Amin A; Refaat A; Zaky I; Elkhateeb N; Sabry M
    Radiother Oncol; 2014 Apr; 111(1):35-40. PubMed ID: 24560760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
    Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
    Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma.
    Krishnatry R; Manjali JJ; Chinnaswamy G; Chatterjee A; Goda JS; Janu A; Sahu A; Jalali R; Gupta T
    Jpn J Clin Oncol; 2021 Apr; 51(5):762-768. PubMed ID: 33521824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.
    Broniscer A; Baker JN; Tagen M; Onar-Thomas A; Gilbertson RJ; Davidoff AM; Pai Panandiker AS; Leung W; Chin TK; Stewart CF; Kocak M; Rowland C; Merchant TE; Kaste SC; Gajjar A
    J Clin Oncol; 2010 Nov; 28(31):4762-8. PubMed ID: 20921456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma.
    Pai Panandiker AS; Wong JK; Nedelka MA; Wu S; Gajjar A; Broniscer A
    Pediatr Blood Cancer; 2014 Jul; 61(7):1180-3. PubMed ID: 24482196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience.
    Negretti L; Bouchireb K; Levy-Piedbois C; Habrand JL; Dhermain F; Kalifa C; Grill J; Dufour C
    J Neurooncol; 2011 Sep; 104(3):773-7. PubMed ID: 21327862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.